Cargando…

Prevalence and associates of non-fatal overdose among people who inject drugs in Saveh, Iran

BACKGROUND: As a public health issue, non-fatal overdose (NFOD) is highly prevalent among people who inject drugs (PWID). This can lead to an elevated risk of future overdose, causing various harms including possible death. It is essential to improve knowledge concerning this problem and its associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Armoon, Bahram, Griffiths, Mark D., Bayani, Azadeh, Mohammadi, Rasool, Ahounbar, Elaheh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351099/
https://www.ncbi.nlm.nih.gov/pubmed/35927753
http://dx.doi.org/10.1186/s13722-022-00325-2
_version_ 1784762365893410816
author Armoon, Bahram
Griffiths, Mark D.
Bayani, Azadeh
Mohammadi, Rasool
Ahounbar, Elaheh
author_facet Armoon, Bahram
Griffiths, Mark D.
Bayani, Azadeh
Mohammadi, Rasool
Ahounbar, Elaheh
author_sort Armoon, Bahram
collection PubMed
description BACKGROUND: As a public health issue, non-fatal overdose (NFOD) is highly prevalent among people who inject drugs (PWID). This can lead to an elevated risk of future overdose, causing various harms including possible death. It is essential to improve knowledge concerning this problem and its associated risk factors to inform overdose prevention and assistance programs. The primary aim of the present study was to determine the prevalence of NFOD and associated risk factors among PWID in Saveh, Iran. METHODS: In the present cross-sectional study, 272 PWID living in Saveh, Iran were interviewed face-to-face using a structured survey. Data concerning socio-demographics, substance use, risky behaviors, and services utilization data were collected. The outcome variable (i.e., NFOD) was assessed by answering “Yes” to the question: “In the past three months, have you ever overdosed (at least once) by accident?” RESULTS: The prevalence of NFOD among PWID in the past three months was 54%. The characteristics and behaviors that were associated with an increased risk of experiencing NFOD in the past three months were being of older age (AOR = 5.2, p < 0.05), drug use initiation under the age of 22 years (AOR = 7.8, p < 0.05), being an alcohol user (AOR = 3.0, p < 0.05), and being a simultaneous multiple drug user (AOR = 5.8, p < 0.05). Also, more recent initiates to injecting (< 2 years) had an increased risk of experiencing a non-fatal overdose in the past three months. Findings also indicated that those who (i) attended a needle and syringe program (AOR: 0.3, p < 0.05), (ii) were visited by a general practitioner (AOR: 0.03, p < 0.05), and (iii) received a psychosocial intervention (AOR: 0.1, p < 0.05) were 0.3, 0.03 and 0.1 times less likely to report non-fatal overdosing than other participants, respectively. CONCLUSIONS: The results indicate that intervention and prevention initiatives seeking to reduce NFOD among PWID should not only be focused on the primary drug used but also the use of alcohol and polysubstance use. Specific and tailored psychological interventions combined with pharmacotherapy may be highly beneficial for PWID who experience more severe types of substance use, including alcohol use disorders and/or polysubstance abuse.
format Online
Article
Text
id pubmed-9351099
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93510992022-08-05 Prevalence and associates of non-fatal overdose among people who inject drugs in Saveh, Iran Armoon, Bahram Griffiths, Mark D. Bayani, Azadeh Mohammadi, Rasool Ahounbar, Elaheh Addict Sci Clin Pract Research BACKGROUND: As a public health issue, non-fatal overdose (NFOD) is highly prevalent among people who inject drugs (PWID). This can lead to an elevated risk of future overdose, causing various harms including possible death. It is essential to improve knowledge concerning this problem and its associated risk factors to inform overdose prevention and assistance programs. The primary aim of the present study was to determine the prevalence of NFOD and associated risk factors among PWID in Saveh, Iran. METHODS: In the present cross-sectional study, 272 PWID living in Saveh, Iran were interviewed face-to-face using a structured survey. Data concerning socio-demographics, substance use, risky behaviors, and services utilization data were collected. The outcome variable (i.e., NFOD) was assessed by answering “Yes” to the question: “In the past three months, have you ever overdosed (at least once) by accident?” RESULTS: The prevalence of NFOD among PWID in the past three months was 54%. The characteristics and behaviors that were associated with an increased risk of experiencing NFOD in the past three months were being of older age (AOR = 5.2, p < 0.05), drug use initiation under the age of 22 years (AOR = 7.8, p < 0.05), being an alcohol user (AOR = 3.0, p < 0.05), and being a simultaneous multiple drug user (AOR = 5.8, p < 0.05). Also, more recent initiates to injecting (< 2 years) had an increased risk of experiencing a non-fatal overdose in the past three months. Findings also indicated that those who (i) attended a needle and syringe program (AOR: 0.3, p < 0.05), (ii) were visited by a general practitioner (AOR: 0.03, p < 0.05), and (iii) received a psychosocial intervention (AOR: 0.1, p < 0.05) were 0.3, 0.03 and 0.1 times less likely to report non-fatal overdosing than other participants, respectively. CONCLUSIONS: The results indicate that intervention and prevention initiatives seeking to reduce NFOD among PWID should not only be focused on the primary drug used but also the use of alcohol and polysubstance use. Specific and tailored psychological interventions combined with pharmacotherapy may be highly beneficial for PWID who experience more severe types of substance use, including alcohol use disorders and/or polysubstance abuse. BioMed Central 2022-08-04 2022 /pmc/articles/PMC9351099/ /pubmed/35927753 http://dx.doi.org/10.1186/s13722-022-00325-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Armoon, Bahram
Griffiths, Mark D.
Bayani, Azadeh
Mohammadi, Rasool
Ahounbar, Elaheh
Prevalence and associates of non-fatal overdose among people who inject drugs in Saveh, Iran
title Prevalence and associates of non-fatal overdose among people who inject drugs in Saveh, Iran
title_full Prevalence and associates of non-fatal overdose among people who inject drugs in Saveh, Iran
title_fullStr Prevalence and associates of non-fatal overdose among people who inject drugs in Saveh, Iran
title_full_unstemmed Prevalence and associates of non-fatal overdose among people who inject drugs in Saveh, Iran
title_short Prevalence and associates of non-fatal overdose among people who inject drugs in Saveh, Iran
title_sort prevalence and associates of non-fatal overdose among people who inject drugs in saveh, iran
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351099/
https://www.ncbi.nlm.nih.gov/pubmed/35927753
http://dx.doi.org/10.1186/s13722-022-00325-2
work_keys_str_mv AT armoonbahram prevalenceandassociatesofnonfataloverdoseamongpeoplewhoinjectdrugsinsavehiran
AT griffithsmarkd prevalenceandassociatesofnonfataloverdoseamongpeoplewhoinjectdrugsinsavehiran
AT bayaniazadeh prevalenceandassociatesofnonfataloverdoseamongpeoplewhoinjectdrugsinsavehiran
AT mohammadirasool prevalenceandassociatesofnonfataloverdoseamongpeoplewhoinjectdrugsinsavehiran
AT ahounbarelaheh prevalenceandassociatesofnonfataloverdoseamongpeoplewhoinjectdrugsinsavehiran